Dopexamine increases inotropic state and rate of relaxation independent of changes in heart rate. Dopexamine has a chronotropic effect and results in a decrease in systemic vascular resistance. Dopexamine has a spectrum of action that should be useful in patients with severe heart failure.

, , , , , , , , , , , , , , , , , , , , ,
hdl.handle.net/1765/4183
British Journal of Clinical Pharmacology
Erasmus MC: University Medical Center Rotterdam

Jaski, B. E., Wijns, W., Foulds, R., & Serruys, P. (1986). The haemodynamic and myocardial effects of dopexamine: a new B2-adrenoceptor and dopaminergic agonist. British Journal of Clinical Pharmacology, 21, 393–400. Retrieved from http://hdl.handle.net/1765/4183